Results 181 to 190 of about 7,402 (232)

An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer. [PDF]

Vaccines (Basel)
Forčić D, Mršić K, Perić-Balja M, Kurtović T, Ramić S, Silovski T, Pedišić I, Milas I, Halassy B.   +8 more
europepmc   +1 more source

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

, 2017
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer, Virginie Nourtier, Xavier Préville, Éric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel   +13 more
openalex   +1 more source

Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape. [PDF]

World J Gastrointest Oncol
Xiao R, Jin H, Huang F, Huang B, Wang H, Wang YG.   +5 more
europepmc   +1 more source

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

, 2017
Eric Ring, Rong Li, Blake P. Moore, Li Nan, Virginia Kelly, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Jianmei W. Leavenworth, G. Yancey Gillespie, Gregory K. Friedman   +10 more
openalex   +1 more source

Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy. [PDF]

Int J Mol Sci
Bhatt DK, Daemen T.
europepmc   +1 more source

Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry. [PDF]

Front Immunol
Dong W, Luo Y, He D, Zhang M, Zeng J, Chen Y.   +5 more
europepmc   +1 more source

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

, 2018
Marie‐Claude Bourgeois‐Daigneault, Dominic G. Roy, Amelia S. Aitken, Nader El Sayes, Nikolas T. Martin, Oliver Varette, Theresa Falls, Lauren Elizabeth St-Germain, Adrian Pelin, Brian D. Lichty, David F. Stojdl, Guy Ungerechts, Jean‐Simon Diallo, John C. Bell   +13 more
openalex   +1 more source

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. [PDF]

Nat Commun
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic AHF, Kress A, Carter-Timofte ME, Holm E, van der Horst D, Kollmann CF, Liu Z, Wang C, Hoang HD, Kovalenko E, Chrysopoulou M, Twayana KS, Ottosen RN, Svenningsen EB, Begnini F, Kiib AE, Kromm FEH, Weiss HJ, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou WH, Schack VR, Holm CK, Zheng Y, Ruzek M, Kalucka J, de la Vega L, Elgaher WAM, Korshoej AR, Lin R, Hiscott J, Poulsen TB, O'Neill LA, Roy DG, Rinschen MM, van Montfoort N, Diallo JS, Farin HF, Alain T, Olagnier D.   +50 more
europepmc   +1 more source

Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. [PDF]

EBioMedicine
Schäfer TE, Knol LI, Haas FV, Hartley A, Pernickel SCS, Jády A, Finkbeiner MSC, Achberger J, Arelaki S, Modic Ž, Schröer K, Zhang W, Schmidt B, Schuster P, Haferkamp S, Doerner J, Gebauer F, Ackermann M, Kvasnicka HM, Kulkarni A, Bots STF, Kemp V, Hawinkels LJAC, Poetsch AR, Hoeben RC, Ehrhardt A, Marchini A, Ungerechts G, Ball CR, Engeland CE.   +29 more
europepmc   +1 more source

Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. [PDF]

Int J Mol Sci
Volovat SR, Scripcariu DV, Vasilache IA, Stolniceanu CR, Volovat C, Augustin IG, Volovat CC, Ostafe MR, Andreea-Voichița SG, Bejusca-Vieriu T, Lungulescu CV, Sur D, Boboc D.   +12 more
europepmc   +1 more source